Wegovy — Cigna

Major Adverse Cardiovascular Event(s) Risk Reduction in a Patient with Established Cardiovascular Disease with Overweight or Obesity

Initial criteria

Patient is ≥ 18 years of age
Patient has a current BMI ≥ 27 kg/m2
Patient has had a prior myocardial infarction OR prior stroke (excluding transient ischemic attack) OR has a history of symptomatic peripheral arterial disease evidenced by ONE of: intermittent claudication with ankle-brachial index < 0.85, peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease
According to the prescriber, the medication will be used in combination with optimized pharmacotherapy for established cardiovascular disease
The medication will be used concomitantly with behavioral modification and a reduced-calorie diet

Patient is ≥ 18 years of age
At baseline BMI ≥ 27 kg/m2
Patient continues to have established cardiovascular disease (myocardial infarction, stroke, or symptomatic peripheral arterial disease as defined)
According to the prescriber, Wegovy will be used in combination with optimized pharmacotherapy for established cardiovascular disease
The medication will be used concomitantly with behavioral modification and a reduced-calorie diet

1 year